MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

CTKB — Cytek Biosciences, Inc. Common Stock

Nasdaq

Cytek Biosciences, Inc. Common Stock

CompareBack to Screener
$5.87
+0.06(+1.03%)
O
5.86
H
5.94
L
5.75
V
1.1M
⏱️ End-of-day dataAs of Oct 2, 2026

Chart

About CTKB

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.

IndustryLABORATORY ANALYTICAL INSTRUMENTS
SectorNot available
IPO DateJul 23, 2021
Employees702
Stock ExchangeNasdaq
Ticker SymbolCTKB

Key Financial Statistics

Market Cap$763.00M
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$3.31 - $6.18
52-Week Avg Volume1.09M
VWAP$5.83
Transactions11,433
Total Recorded Bars1,305 days